A three-hour bidding war broke out Tuesday over the former headquarters of a bankrupt local tech company.
Commonwealth Biotechnologies
Stalking horse backs down
The local investment fund that had made a $4 million bid on the last remaining asset of a bankrupt local firm has pulled out.
A stalking horse emerges
A Richmond real estate investment fund wants to buy the last remaining asset of a bankrupt local biotech firm.
He has had enough
Bill Guo wants shareholders of a bankrupt local biotech firm to change the size of its board to a single director. And you can probably guess who he wants to be No. 1.
The Pipeline: Commercial Real Estate Round Up for 4.30.10
Hanover County purchased a 14,400 square feet flex condo unit at 9732-9742 Atlee Commons Road in Hanover for $1.7 million. The Witmeyer Law Firm leased 1,920 square feet at 10035 Sliding Hill Road in Hanover.
Commonwealth Biotechnologies gets delisting warning
Commonwealth Biotechnologies, a Chesterfield-based biotech firm that has made several international deals lately, received a delisting notice from NASDAQ for failure to meet certain filing rules. The stock is down $0.11, or 17 percent, $0.53 in morning trading. (NASDAQ: CBTE) According to the notice dated July 24, Commonwealth failed to maintain a minimum stockholder’s equity… Read more »
Two local labs sign deal
Chesterfield biotech firm Commonwealth Biotechnologies plans to sell off segments of its business to Bostwick Laboratories, which is based in the West End. Bostwick plans to go public this year.
Commonwealth Biotechnologies stock surges
Shares of Chesterfield-based Commonwealth Biotechnologies almost doubled Thursday, closing at $0.76 a share. Stocks that trade for less than $1 are notoriously volatile, but this seems to be on account of a deal with a of GL Biochem in Shanghai. (You can read about that here.) The company is also losing less than last year,… Read more »
Biotech company expands in China
Stock in Chesterfield-based Commonwealth Biotechnologies nearly doubled on news that the company is planning to acquire GL Biochem in Shanghai. CBI researches drugs for companies that develop them.
BioTech park lands British firm
A British firm that has come up with a product to kill high-powered bacteria has become the 56th company in the Virginia BioTechnology Research Park in downtown Richmond. Biocontrol Ltd. of London opened an office in an existing building in the park and will operate as a U.S. based affiliate under the name Biocontrol International… Read more »